Editors

EDITOR-IN-CHIEF

Gregory W. Daniel, PhD, MPH, RPh
Eli Lilly and Company, United States

EDITOR-IN-CHIEF EMERITUS

Michael R. Hamrell, PhD
Moriah Consultants, United States 

ASSOCIATE EDITORS

Theresa Allio, PhD, RAC
Bayer Pharmaceuticals, New York City Area, United States

Greg Ball, PhD
ASAP Process Consulting, LLC, United States

Dayle H. Cohen, PhD
PPD Inc., Part of Thermo Fisher Scientific, United States

Richard Day, MD, FRACP
St Vincent's Hospital, Australia

Jeffrey Garwin, PhD, MD
PPD Inc: Pharmaceutical Product Development Inc., United States

Kevin Haynes, PharmD
Healthcore Inc., Philadelphia, United States

Lisa Kammerman, PhD
Kammerman Consulting, Chevy Chase, United States

Patrick Lam, PhD
Hong Kong Science and Technology Parks Corporation, Hong Kong SAR, China

Grazyna (Gracie) Lieberman, Dr
N-Power Medicine, Redwood City, United States

Nicole Mahoney, PhD
Novartis Pharma AG, Rockville, United States

Munish Mehra, PhD
Tigermed, Gaithersburg, United States

Melodi McNeil, RPh, MS
AbbVie, Inc., Silver Spring, United States

Estelle Russek-Cohen, PhD
ERCStatLLC, Washington, United States

Richard C. Zink, PhD
JMP Statistical Discovery LLC, NC, United States

MANAGING EDITOR

Sandra Blumenrath, MS, PhD
DIA, United States

EDITORIAL BOARD

Theresa Allio, PhD, RAC
Bayer Pharmaceuticals, USA

Josephine Babiarz, JD
Esq. Arlington, USA

David R. Bristol, PhD
Statistical Consulting Services LLC, Winston Salem, USA

Joseph C. Cappelleri, PhD, MPH, MS
Pfizer Inc., USA

Joseph A. DiMasi, PhD
Tufts University, Boston, USA

Todd A. Durham, PhD
Novan, Inc., USA

Alan M. Hochberg, BS
Genentech, Inc., USA
Patrick Lam, PhD
Hong Kong Science and Technology Parks Corporation, Shatin, Hong Kong SAR

Wendy Lipworth, MBBS, PhD
The University of Sydney, Australia

Shunsuke Ono, PhD
The University of Tokyo, Japan

Peter J. Pitts, BA
Adherent Health, LLC; Center for Medicine in the Public Interest, USA

Ronald J. Portman, MD
Novartis Pharmaceutical Corporation, USA

Ramses F. Sadek, PhD
Augusta University, USA